抗生素硝羟喹啉及相关化合物抑制组织蛋白酶B的新机制。 - Suppr

Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds.

作者信息

Mirković Bojana, Renko Miha, Turk Samo, Sosič Izidor, Jevnikar Zala, Obermajer Nataša, Turk Dušan, Gobec Stanislav, Kos Janko

机构信息

Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.

出版信息

ChemMedChem. 2011 Aug 1;6(8):1351-6. doi: 10.1002/cmdc.201100098. Epub 2011 May 20.

DOI:10.1002/cmdc.201100098

PMID:21598397

Abstract

摘要

相似文献

Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds.抗生素硝羟喹啉及相关化合物抑制组织蛋白酶B的新机制。

ChemMedChem. 2011 Aug 1;6(8):1351-6. doi: 10.1002/cmdc.201100098. Epub 2011 May 20.

Cathepsin B inhibitors: Further exploration of the nitroxoline core.组织蛋白酶B抑制剂：对硝氧喹啉核心结构的进一步探索。

Bioorg Med Chem Lett. 2018 Apr 15;28(7):1239-1247. doi: 10.1016/j.bmcl.2018.02.042. Epub 2018 Feb 23.

SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents.一些基于苯乙酮苯腙的吡唑衍生物作为组织蛋白酶抑制剂的构效关系研究。

Bioorg Chem. 2017 Dec;75:38-49. doi: 10.1016/j.bioorg.2017.08.006. Epub 2017 Aug 31.

Synthesis of Novel Nitroxoline Analogs with Potent Cathepsin B Exopeptidase Inhibitory Activity.新型硝呋太尔类似物的合成及其对组织蛋白酶 B 外肽酶抑制活性的研究。

ChemMedChem. 2020 Dec 15;15(24):2477-2490. doi: 10.1002/cmdc.202000402. Epub 2020 Sep 21.

2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.2,5-二芳基恶二唑及其前体作为组织蛋白酶B、H和L的新型抑制剂

Bioorg Chem. 2016 Aug;67:64-74. doi: 10.1016/j.bioorg.2016.05.003. Epub 2016 May 14.

Some thiocarbamoyl based novel anticathepsin agents.一些基于硫代氨基甲酰的新型组织蛋白酶抑制剂。

Bioorg Chem. 2020 Nov;104:104174. doi: 10.1016/j.bioorg.2020.104174. Epub 2020 Aug 27.

Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.新型组织蛋白酶 B 抑制剂的研发：结合生物等排替换和基于结构的设计探索硝呋罗啉衍生物的构效关系。

J Med Chem. 2013 Jan 24;56(2):521-33. doi: 10.1021/jm301544x. Epub 2013 Jan 4.

Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.喹唑啉衍生物作为组织蛋白酶B、H和L抑制剂及细胞增殖剂。

Int J Biol Macromol. 2017 Jan;94(Pt A):719-727. doi: 10.1016/j.ijbiomac.2016.10.001. Epub 2016 Oct 22.

SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.基于查耳酮的不同功能化腙及其环化衍生物作为哺乳动物组织蛋白酶B和组织蛋白酶H抑制剂的构效关系研究

Bioorg Med Chem. 2014 Aug 1;22(15):4233-45. doi: 10.1016/j.bmc.2014.05.037. Epub 2014 May 24.

Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity.芳基金属硝呋太尔衍生物通过抑制组织蛋白酶 B 的活性抑制肿瘤细胞侵袭。

Inorg Chem. 2019 Sep 16;58(18):12334-12347. doi: 10.1021/acs.inorgchem.9b01882. Epub 2019 Aug 29.

引用本文的文献

Insights into a water-mediated catalytic triad architecture in CE20 carbohydrate esterases.对CE20碳水化合物酯酶中水介导催化三联体结构的深入了解。

Nat Commun. 2025 Jul 31;16(1):7034. doi: 10.1038/s41467-025-62387-5.

Neutral pH-Selective Inhibition of Cytosolic Cathepsin B: A Novel Drug Targeting Strategy for Traumatic Brain Injury and Alzheimer's Disease.中性pH值下对胞质组织蛋白酶B的选择性抑制：一种针对创伤性脑损伤和阿尔茨海默病的新型药物靶向策略

ACS Chem Biol. 2025 Aug 15;20(8):1841-1848. doi: 10.1021/acschembio.5c00463. Epub 2025 Jul 23.

Identification and targeting of metastatic biomarkers for hepatocellular carcinoma therapeutics using small molecules library of curcumin analogues.利用姜黄素类似物小分子文库鉴定和靶向肝细胞癌治疗的转移生物标志物

Mol Divers. 2025 Feb;29(1):503-517. doi: 10.1007/s11030-024-10871-3. Epub 2024 Apr 30.

Deciphering neuroprotective mechanism of nitroxoline in cerebral ischemia: network pharmacology and molecular modeling-based investigations.解析硝氧喹啉在脑缺血中的神经保护机制：基于网络药理学和分子模拟的研究

Mol Divers. 2024 Dec;28(6):3993-4015. doi: 10.1007/s11030-023-10791-8. Epub 2024 Jan 17.

Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease.蛋白酶活性的调节：超越人类健康与疾病中的活性位点。

Int J Mol Sci. 2023 Dec 4;24(23):17120. doi: 10.3390/ijms242317120.

Isolation of Nocuolin A and Synthesis of New Oxadiazine Derivatives. Design, Synthesis, Molecular Docking, Apoptotic Evaluation, and Cathepsin B Inhibition.分离诺库林 A 和合成新的噁二嗪衍生物。设计、合成、分子对接、凋亡评价和组织蛋白酶 B 抑制。

Mar Drugs. 2023 Apr 29;21(5):284. doi: 10.3390/md21050284.

Synthesis of Bioactive Aminomethylated 8-Hydroxyquinolines via the Modified Mannich Reaction.通过改良 Mannich 反应合成具有生物活性的氨甲基化 8-羟基喹啉。

Int J Mol Sci. 2023 Apr 26;24(9):7915. doi: 10.3390/ijms24097915.

Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins.二肽衍生炔烃作为半胱氨酸组织蛋白酶的高效和选择性不可逆抑制剂。

J Med Chem. 2023 Mar 23;66(6):3818-3851. doi: 10.1021/acs.jmedchem.2c01360. Epub 2023 Mar 3.

Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond.抗菌药物中的螯合作用：从硝羟喹啉到头孢地尔及其他。

Antibiotics (Basel). 2022 Aug 15;11(8):1105. doi: 10.3390/antibiotics11081105.

Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy.新型组织蛋白酶 X 抑制剂的体外和体内评价及其增强组织蛋白酶 B 导向抗肿瘤治疗的能力。

Cell Mol Life Sci. 2022 Jan 6;79(1):34. doi: 10.1007/s00018-021-04117-w.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献